Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI

Breast Cancer Research and Treatment

Volumn 78, Issue 1, 2003, Pages 51-58

  Cheung, Yun Chung ^a,b,c   Chen, Shih Cheh ^a   Su, Min Ying ^d   See, Lai Chu ^a   Hsueh, Swei ^a   Chang, Hsien Kun ^a   Lin, Yung Chang ^a   Tsai, Chien Sheng ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d NONE

Author keywords

Advanced breast cancer; Chemotherapeutic response; Chemotherapy; Magnetic resonance imaging; Preoperative planning; Size monitoring; Treatment

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; PACLITAXEL;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER SIZE; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION REGULATION; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; EPIRUBICIN; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MASTECTOMY; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PACLITAXEL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 0037368147     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022153327339     Document Type: Article

References (25)

1. Bonadonna G: Conceptual and practical advanced in the management of breast cancer. J Clin Oncol 7: 1380-1397, 1989
2. Schwartz GF, Cantor RI, Biermann WA: Neoadjuvant chemotherapy before definite treatment for stage III carcinoma of the breast. Arch Surg 122: 1430-1434, 1987
3. Lopez MJ, Andriole DP, Kraybill WG, Khojasteh A: Multimodal therapy in locally advanced breast carcinoma. Am J Surg 160: 669-675, 1990
4. Hortobagyi GN, Ames FC, Buzdar AU, Kau SW, McNeese MD, Paulus D, Hug V, Holmes FA, Romsdahl MM, Fraschini G: Management of stage III primary breast cancer with primary chemotherapy, surgery and radiation therapy. Cancer 62: 2507-2516, 1988
5. Swain SM, Sorace RA, Bagley CS, Danforth Jr DN, Bader J, Wesley MN, Steinberg SM, Lippman ME: Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer. Cancer Res 47: 3889-3894, 1987
6. Booser D, Hortobagyi G: Treatment of locally advanced breast cancer. Semin Oncol 19: 278-285, 1992
7. Singletary S, McNeese M, Hortobagyi G: Feasibility of breast-conservation chemotherapy for locally advanced breast carcinoma. Cancer 69: 2849-2852, 1992
8. Hortobagyi GN, Blumenschein GR, Spanos W, Montague ED, Buzdar AU, Yap HY, Schell F: Multimodal treatment of locoregional advanced breast cancer. Cancer 51: 763-768, 1983
9. Feldman L, Hortobagyi G, Buzdar A, Ames F, Blumeschein G: Pathological assessment of response to induction chemotherapy in breast cancer. Cancer Res 46: 2578-2581, 1986
10. Segel M, Paulus D, Hortobagyi G: Advanced primary breast cancer: assessment at mammography of response to induction chemotherapy. Radiology 169: 49-54, 1988
11. Cocconi G, Di Blasio B, Alberti G, Bisagni G, Botti E, Peracchia G: Problems in evaluation response of primary breast cancer to systemic therapy. Breast Cancer Res Treat 4: 309-313, 1984
12. Gilles R, Guinebretiere JM, Toussaint C, Spielman M, Rietjens M, Petit JY, Contesso G, Masselot J, Vanel D: Locally advanced breast cancer: contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy. Radiology 191: 633-638, 1994
13. Abraham DC, Jones RC, Jones SE, Cheek JH, Peters GN, Knox SM, Grant MD, Hampe DW, Savino DA, Harms SE: Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging. Cancer 78: 91-100, 1996
14. Drew PJ, Kerin MJ, Mahapatra T, Malone C, Monson JR, Turnhull LW, Fox JN: Evaluation of response to neoadjuvant chemoradiotherapy for locally advanced breast cancer with dynamic contrast-enhanced MRI of the breast. Eur J Surg Oncol 27: 617-620, 2001
15. Trecate G, Ceglia E, Stabile F. Tesoro-Tess JD, Mariani G, Zambetti M, Musumeci R: Locally advanced breast cancer treated with primary chemotherapy: comparison between magnetic imaging and pathologic evaluation of residual disease. Tumori 85: 220-228, 1999
16. Padhani AR, Ollivier L: The RECIST criteria: implications for diagnostic radiologists. Br J Radiol 74: 983-986, 2001
17. James K, Eisenhauer E, Christian M, Terenziani M, Vena D, Muldal A, Therasse P: Measuring response in solid tumors: unidimensional versus bidimensional measurement. J Nat Cancer Inst 91: 523-528, 1999
18. McNeil BJ, Hanley JA: Statistical approaches to the analysis of receiving operating characteristic (ROC) curves. Med Decision Making 4: 137-150, 1988
19. Schwartz GF, Birchansky CA, Komarnicky LT, Mansfield CM, Canton RI. Biermann WA, Fellin FM, McFarlane J: Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast. Cancer 73: 362-369, 1994
20. Khanna MM, Mark RJ, Silverstein MJ, Juillard G, Lewinsky B, Guiliano AE: Breast conservation management of breast tumors 4 cm or larger. Arch Surg 127: 1038-1043, 1992
21. Sataloff DM, Mason BA, Prestipino AJ, Seinige UL, Lieber CP, Baloch Z: Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome. Am J Coll Surg 180: 297-306, 1995
22. Davis PL, McCarty SK: Technologic consideration for breast tumor size assessment. MRI Clin N Am 2: 623-631, 1994
23. Kuhl CK, Mielcareck P, Klaschik S, Leutner C, Wardelmann E, Gieseke J, Schild HH: Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 211: 101-110, 1999
24. Orel SG, Schnall MD, LiVolsi VA, Troupin RH: Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology 190: 485-493, 1994
25. Knopp MV, Brix G, Junkermann HJ, Sinn HP: MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy. MRI Clin N Am 2: 633-658, 1994